Crescent Capital BDC, Inc. (NASDAQ:CCAP) Short Interest Update

Crescent Capital BDC, Inc. (NASDAQ:CCAP) was the target of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 139,400 shares, an increase of 26.3% from the March 15th total of 110,400 shares. Currently, 0.4% of the company’s stock are short sold. Based on an average daily volume of 143,900 shares, the days-to-cover ratio is presently 1.0 days.

Institutional Investors Weigh In On Crescent Capital BDC

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Raymond James Financial Inc. bought a new stake in Crescent Capital BDC during the 4th quarter valued at approximately $3,750,000. Franklin Resources Inc. lifted its holdings in shares of Crescent Capital BDC by 35.2% during the third quarter. Franklin Resources Inc. now owns 256,279 shares of the company’s stock worth $4,726,000 after buying an additional 66,713 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Crescent Capital BDC in the fourth quarter valued at approximately $661,000. Redhawk Wealth Advisors Inc. acquired a new stake in shares of Crescent Capital BDC in the fourth quarter worth $659,000. Finally, Stifel Financial Corp increased its position in Crescent Capital BDC by 53.1% during the third quarter. Stifel Financial Corp now owns 66,470 shares of the company’s stock worth $1,230,000 after acquiring an additional 23,055 shares during the period. 49.46% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have issued reports on CCAP shares. Keefe, Bruyette & Woods decreased their target price on shares of Crescent Capital BDC from $20.00 to $18.50 and set an “outperform” rating for the company in a research note on Tuesday, April 8th. Wells Fargo & Company cut their price target on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a research note on Friday, February 21st. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $18.90.

Crescent Capital BDC Stock Performance

Shares of NASDAQ CCAP opened at $15.13 on Tuesday. The business’s 50-day simple moving average is $17.12 and its 200-day simple moving average is $18.39. Crescent Capital BDC has a 52 week low of $13.54 and a 52 week high of $20.19. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.26 and a current ratio of 1.32. The firm has a market cap of $560.75 million, a price-to-earnings ratio of 7.60 and a beta of 0.56.

Crescent Capital BDC (NASDAQ:CCAP) last released its quarterly earnings results on Wednesday, February 19th. The company reported $0.55 EPS for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.01). The firm had revenue of $46.40 million during the quarter, compared to the consensus estimate of $47.27 million. Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. As a group, equities research analysts expect that Crescent Capital BDC will post 2.09 earnings per share for the current fiscal year.

Crescent Capital BDC Announces Dividend

The company also recently declared a dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were issued a dividend of $0.05 per share. The ex-dividend date was Friday, February 28th. Crescent Capital BDC’s dividend payout ratio (DPR) is 84.42%.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.